Works matching IS 10837159 AND DT 2018 AND VI 23 AND IP 10
Results: 21
Improved Detection of Circulating Epithelial Cells in Patients with Intraductal Papillary Mucinous Neoplasms.
- Published in:
- 2018
- By:
- Publication type:
- Correction Notice
In Reply.
- Published in:
- Oncologist, 2018, v. 23, n. 10, p. e120, doi. 10.1634/theoncologist.2018-0374
- By:
- Publication type:
- Article
Regarding "Improved Detection of Circulating Epithelial Cells in Patients with Intraductal Papillary Mucinous Neoplasms".
- Published in:
- Oncologist, 2018, v. 23, n. 10, p. e119, doi. 10.1634/theoncologist.2018-0148
- By:
- Publication type:
- Article
Adjuvant Anthracyclines in Breast Cancer: What Is Their Role?
- Published in:
- Oncologist, 2018, v. 23, n. 10, p. 1153, doi. 10.1634/theoncologist.2017-0672
- By:
- Publication type:
- Article
A Case of Nivolumab‐Induced Bullous Pemphigoid: Review of Dermatologic Toxicity Associated with Programmed Cell Death Protein‐1/Programmed Death Ligand‐1 Inhibitors and Recommendations for Diagnosis and Management.
- Published in:
- Oncologist, 2018, v. 23, n. 10, p. 1119, doi. 10.1634/theoncologist.2018-0128
- By:
- Publication type:
- Article
Adjuvant Subcutaneous Trastuzumab for HER2‐Positive Early Breast Cancer: Subgroup Analyses of Safety and Active Medical Conditions by Body Weight in the SafeHer Phase III Study.
- Published in:
- Oncologist, 2018, v. 23, n. 10, p. 1137, doi. 10.1634/theoncologist.2018-0065
- By:
- Publication type:
- Article
NGR‐hTNF and Doxorubicin as Second‐Line Treatment of Patients with Small Cell Lung Cancer.
- Published in:
- Oncologist, 2018, v. 23, n. 10, p. 1133, doi. 10.1634/theoncologist.2018-0292
- By:
- Publication type:
- Article
Pretreatment <sup>18</sup>F‐FDG Uptake Heterogeneity Predicts Treatment Outcome of First‐Line Chemotherapy in Patients with Metastatic Triple‐Negative Breast Cancer.
- Published in:
- Oncologist, 2018, v. 23, n. 10, p. 1144, doi. 10.1634/theoncologist.2018-0001
- By:
- Publication type:
- Article
Selection of Protein Kinase Inhibitors Based on Tumor Tissue Kinase Activity Profiles in Patients with Refractory Solid Malignancies: An Interventional Molecular Profiling Study.
- Published in:
- Oncologist, 2018, v. 23, n. 10, p. 1135, doi. 10.1634/theoncologist.2018-0263
- By:
- Publication type:
- Article
Prognostic Understanding at Diagnosis and Associated Factors in Patients with Advanced Lung Cancer and Their Caregivers.
- Published in:
- Oncologist, 2018, v. 23, n. 10, p. 1218, doi. 10.1634/theoncologist.2017-0329
- By:
- Publication type:
- Article
Pattern and Predictors of Outpatient Palliative Care Referral Among Thoracic Medical Oncologists.
- Published in:
- Oncologist, 2018, v. 23, n. 10, p. 1230, doi. 10.1634/theoncologist.2018-0094
- By:
- Publication type:
- Article
Developing a Roadmap for Interventional Oncology.
- Published in:
- Oncologist, 2018, v. 23, n. 10, p. 1162, doi. 10.1634/theoncologist.2017-0654
- By:
- Publication type:
- Article
Incidence of Thyroid Function Test Abnormalities in Patients Receiving Immune‐Checkpoint Inhibitors for Cancer Treatment.
- Published in:
- Oncologist, 2018, v. 23, n. 10, p. 1236, doi. 10.1634/theoncologist.2017-0375
- By:
- Publication type:
- Article
At What Cost to Clinical Trial Enrollment? A Retrospective Study of Patient Travel Burden in Cancer Clinical Trials.
- Published in:
- Oncologist, 2018, v. 23, n. 10, p. 1242, doi. 10.1634/theoncologist.2017-0628
- By:
- Publication type:
- Article
Global Acceptance of Biosimilars: Importance of Regulatory Consistency, Education, and Trust.
- Published in:
- Oncologist, 2018, v. 23, n. 10, p. 1188, doi. 10.1634/theoncologist.2017-0671
- By:
- Publication type:
- Article
EML4‐ALK Rearrangement and Its Therapeutic Implications in Inflammatory Myofibroblastic Tumors.
- Published in:
- Oncologist, 2018, v. 23, n. 10, p. 1127, doi. 10.1634/theoncologist.2018-0014
- By:
- Publication type:
- Article
Immuno‐Oncology Biomarkers for Gastric and Gastroesophageal Junction Adenocarcinoma: Why PD‐L1 Testing May Not Be Enough.
- Published in:
- Oncologist, 2018, v. 23, n. 10, p. 1171, doi. 10.1634/theoncologist.2018-0034
- By:
- Publication type:
- Article
Trifluridine/Tipiracil (TAS‐102) in Refractory Metastatic Colorectal Cancer: A Multicenter Register in the Frame of the Italian Compassionate Use Program.
- Published in:
- Oncologist, 2018, v. 23, n. 10, p. 1178, doi. 10.1634/theoncologist.2017-0573
- By:
- Publication type:
- Article
Outcomes of Elderly Patients with Advanced Soft Tissue Sarcoma Treated with First‐Line Chemotherapy: A Pooled Analysis of 12 EORTC Soft Tissue and Bone Sarcoma Group Trials.
- Published in:
- Oncologist, 2018, v. 23, n. 10, p. 1250, doi. 10.1634/theoncologist.2017-0598
- By:
- Publication type:
- Article
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Central Nervous System Metastases from Non‐Small Cell Lung Cancer.
- Published in:
- Oncologist, 2018, v. 23, n. 10, p. 1199, doi. 10.1634/theoncologist.2017-0572
- By:
- Publication type:
- Article
Prognostic Factors and Efficacy of First‐Line Chemotherapy in Patients with Advanced Thymic Carcinoma: A Retrospective Analysis of 286 Patients from NEJ023 Study.
- Published in:
- Oncologist, 2018, v. 23, n. 10, p. 1210, doi. 10.1634/theoncologist.2017-0586
- By:
- Publication type:
- Article